ctrl K

Price Alert

Enliven Therapeutics Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

20.24

0.47 (2.38%)

At close: Aug 15, 2025, 3:59 PM

20.22

-0.10%

After-hours: Aug 15, 2025, 05:29 PM EDT

Enliven Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	124.12M	100.14M	75.54M	110.02M
Short-Term Investments	189.32M	153.01M	n/a	41.97M
Long-Term Investments	n/a	n/a	54K	175K
Other Long-Term Assets	7.17M	4.65M	3.98M	1.53M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.69M	13M	2.22M	646K
Total Current Assets	318.13M	266.15M	77.75M	110.67M
Property-Plant & Equipment	458K	1.06M	1.52M	954K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.63M	5.72M	5.54M	2.66M
Total Assets	325.76M	271.87M	83.3M	113.33M
Account Payables	1.34M	532K	3.44M	2.52M
Deferred Revenue	n/a	n/a	5.51M	n/a
Short-Term Debt	n/a	335K	n/a	159K
Other Current Liabilities	204K	21.36M	320K	74K
Total Current Liabilities	15.91M	25.89M	9.71M	5.75M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	67K	150.41M	714K
Total Long-Term Liabilities	n/a	67K	150.41M	150.46M
Total Liabilities	15.91M	25.96M	160.12M	156.22M
Total Debt	n/a	335K	323K	159K
Common Stock	49K	41K	1K	1K
Retained Earnings	-243.47M	-154.45M	-82.86M	-45.2M
Comprehensive Income	55K	141K	-149.75K	-16K
Shareholders Equity	309.85M	245.91M	-76.83M	-42.89M
Total Investments	189.32M	153.01M	54K	42.14M